Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna P Pilbrow

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|December 11, 2007
Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatmentMathew D Littlejohn, Barry R Palmer, A Mark Richards, et al.
International Journal of Molecular Sciences|June 21, 2020
Hydrogen Sulfide Treatment Improves Post-Infarct Remodeling and Long-Term Cardiac Function in CSE Knockout and Wild-Type MiceLeigh J Ellmers, Evelyn M Templeton, Anna P Pilbrow, et al.
American Heart Journal|August 1, 2006
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patientsRichard P Collins, Barry R Palmer, Anna P Pilbrow, et al.
BMC Medical Genomics|December 31, 2008
Genomic selection of reference genes for real-time PCR in human myocardiumAnna P Pilbrow, Leigh J Ellmers, Michael A Black, et al.
Endocrinology|July 26, 2008
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarctionLeigh J Ellmers, Nicola J A Scott, Satyanarayana Medicherla, et al.
Endocrinology|October 19, 2016
Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative SplicingAnna P Pilbrow, Kathy A Lewis, Marilyn H Perrin, et al.
Hypertension (Dallas, Tex. : 1979)|December 6, 2006
Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failureAnna P Pilbrow, Barry R Palmer, Chris M Frampton, et al.
The Journal of Applied Laboratory Medicine|April 18, 2024
Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary SyndromeCharlotte E Greer, Janice Chew-Harris, Philip D Adamson, et al.
Journal of the American Heart Association|September 17, 2021
Acute Decompensated Heart Failure and the Kidney: Physiological, Histological and Transcriptomic Responses to Development and RecoveryMiriam T Rademaker, Anna P Pilbrow, Leigh J Ellmers, et al.
European Heart Journal Open|May 13, 2026
Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromesTaylor Keys, Charlotte Greer, Philip D Adamson, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|December 11, 2007
Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatmentMathew D Littlejohn, Barry R Palmer, A Mark Richards, et al.
International Journal of Molecular Sciences|June 21, 2020
Hydrogen Sulfide Treatment Improves Post-Infarct Remodeling and Long-Term Cardiac Function in CSE Knockout and Wild-Type MiceLeigh J Ellmers, Evelyn M Templeton, Anna P Pilbrow, et al.
American Heart Journal|August 1, 2006
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patientsRichard P Collins, Barry R Palmer, Anna P Pilbrow, et al.
BMC Medical Genomics|December 31, 2008
Genomic selection of reference genes for real-time PCR in human myocardiumAnna P Pilbrow, Leigh J Ellmers, Michael A Black, et al.
Endocrinology|July 26, 2008
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarctionLeigh J Ellmers, Nicola J A Scott, Satyanarayana Medicherla, et al.
Endocrinology|October 19, 2016
Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative SplicingAnna P Pilbrow, Kathy A Lewis, Marilyn H Perrin, et al.
Hypertension (Dallas, Tex. : 1979)|December 6, 2006
Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failureAnna P Pilbrow, Barry R Palmer, Chris M Frampton, et al.
The Journal of Applied Laboratory Medicine|April 18, 2024
Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary SyndromeCharlotte E Greer, Janice Chew-Harris, Philip D Adamson, et al.
Journal of the American Heart Association|September 17, 2021
Acute Decompensated Heart Failure and the Kidney: Physiological, Histological and Transcriptomic Responses to Development and RecoveryMiriam T Rademaker, Anna P Pilbrow, Leigh J Ellmers, et al.
European Heart Journal Open|May 13, 2026
Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromesTaylor Keys, Charlotte Greer, Philip D Adamson, et al.
Pageof 5